{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,2]],"date-time":"2026-09-02T21:44:43Z","timestamp":1788385483085,"version":"build-2803163510"},"reference-count":57,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,5,7]],"date-time":"2022-05-07T00:00:00Z","timestamp":1651881600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,5,7]],"date-time":"2022-05-07T00:00:00Z","timestamp":1651881600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["U24MH100931"],"award-info":[{"award-number":["U24MH100931"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["RF1AG060961"],"award-info":[{"award-number":["RF1AG060961"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["RO1AG054008"],"award-info":[{"award-number":["RO1AG054008"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["RO1NS095252"],"award-info":[{"award-number":["RO1NS095252"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"name":"The Rainwater Charitable Trust"},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"crossref","award":["RO1AG062348"],"award-info":[{"award-number":["RO1AG062348"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["acta neuropathol commun"],"published-print":{"date-parts":[[2022,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Microglia are implicated in Alzheimer\u2019s Disease (AD) pathogenesis. In a middle-aged cohort enriched for neuroinflammation, we asked whether microgliosis was related to neocortical amyloid beta (A<jats:inline-formula><jats:alternatives><jats:tex-math>$$\\upbeta$$<\/jats:tex-math><mml:math xmlns:mml=\"http:\/\/www.w3.org\/1998\/Math\/MathML\">\n                  <mml:mi>\u03b2<\/mml:mi>\n                <\/mml:math><\/jats:alternatives><\/jats:inline-formula>) deposition and neuronal phosphorylated tau (p-tau), and whether microgliosis predicted cognition. Frontal lobe tissue from 191 individuals autopsied with detectable (HIV-D) and undetectable (HIV-U) HIV infection, and 63 age-matched controls were examined. Immunohistochemistry (IHC) was used to evaluate A<jats:inline-formula><jats:alternatives><jats:tex-math>$$\\upbeta$$<\/jats:tex-math><mml:math xmlns:mml=\"http:\/\/www.w3.org\/1998\/Math\/MathML\">\n                  <mml:mi>\u03b2<\/mml:mi>\n                <\/mml:math><\/jats:alternatives><\/jats:inline-formula> plaques and neuronal p-tau, and quantitate microgliosis with markers Iba1, CD163, and CD68 in large regions of cortex. Glia in the A<jats:inline-formula><jats:alternatives><jats:tex-math>$$\\upbeta$$<\/jats:tex-math><mml:math xmlns:mml=\"http:\/\/www.w3.org\/1998\/Math\/MathML\">\n                  <mml:mi>\u03b2<\/mml:mi>\n                <\/mml:math><\/jats:alternatives><\/jats:inline-formula> plaque microenvironment were quantitated by immunofluorescence (IF). The relationship of microgliosis to cognition was evaluated. No relationship between A<jats:inline-formula><jats:alternatives><jats:tex-math>$$\\upbeta$$<\/jats:tex-math><mml:math xmlns:mml=\"http:\/\/www.w3.org\/1998\/Math\/MathML\">\n                  <mml:mi>\u03b2<\/mml:mi>\n                <\/mml:math><\/jats:alternatives><\/jats:inline-formula> or p-tau accumulation and overall severity of microgliosis was discerned. Individuals with uncontrolled HIV had the greatest microgliosis, but fewer A<jats:inline-formula><jats:alternatives><jats:tex-math>$$\\upbeta$$<\/jats:tex-math><mml:math xmlns:mml=\"http:\/\/www.w3.org\/1998\/Math\/MathML\">\n                  <mml:mi>\u03b2<\/mml:mi>\n                <\/mml:math><\/jats:alternatives><\/jats:inline-formula> plaques; they also had higher prevalence of APOE <jats:inline-formula><jats:alternatives><jats:tex-math>$$\\upvarepsilon$$<\/jats:tex-math><mml:math xmlns:mml=\"http:\/\/www.w3.org\/1998\/Math\/MathML\">\n                  <mml:mi>\u03b5<\/mml:mi>\n                <\/mml:math><\/jats:alternatives><\/jats:inline-formula>4 alleles, but died earlier than other groups. HIV group status was the only variable predicting microgliosis over large frontal regions. In contrast, in the A<jats:inline-formula><jats:alternatives><jats:tex-math>$$\\upbeta$$<\/jats:tex-math><mml:math xmlns:mml=\"http:\/\/www.w3.org\/1998\/Math\/MathML\">\n                  <mml:mi>\u03b2<\/mml:mi>\n                <\/mml:math><\/jats:alternatives><\/jats:inline-formula> plaque microenvironment, APOE <jats:inline-formula><jats:alternatives><jats:tex-math>$$\\upvarepsilon$$<\/jats:tex-math><mml:math xmlns:mml=\"http:\/\/www.w3.org\/1998\/Math\/MathML\">\n                  <mml:mi>\u03b5<\/mml:mi>\n                <\/mml:math><\/jats:alternatives><\/jats:inline-formula>4 status and sex were dominant predictors of glial infiltrates, with smaller contributions of HIV status. Cognition correlated with large-scale microgliosis in HIV-D, but not HIV-U, individuals. In this autopsy cohort, over large regions of cortex, HIV status predicts microgliosis, whereas in the A<jats:inline-formula><jats:alternatives><jats:tex-math>$$\\upbeta$$<\/jats:tex-math><mml:math xmlns:mml=\"http:\/\/www.w3.org\/1998\/Math\/MathML\">\n                  <mml:mi>\u03b2<\/mml:mi>\n                <\/mml:math><\/jats:alternatives><\/jats:inline-formula> plaque microenvironment, traditional risk factors of AD (APOE <jats:inline-formula><jats:alternatives><jats:tex-math>$$\\upvarepsilon$$<\/jats:tex-math><mml:math xmlns:mml=\"http:\/\/www.w3.org\/1998\/Math\/MathML\">\n                  <mml:mi>\u03b5<\/mml:mi>\n                <\/mml:math><\/jats:alternatives><\/jats:inline-formula>4 and sex) are stronger determinants. While microgliosis does not predict neurodegenerative protein deposition, it does predict cognition in HIV-D. Increased neuroinflammation does not initiate amyloid deposition in a younger group with enhanced genetic risk. However, once A<jats:inline-formula><jats:alternatives><jats:tex-math>$$\\upbeta$$<\/jats:tex-math><mml:math xmlns:mml=\"http:\/\/www.w3.org\/1998\/Math\/MathML\">\n                  <mml:mi>\u03b2<\/mml:mi>\n                <\/mml:math><\/jats:alternatives><\/jats:inline-formula> deposits are established, APOE <jats:inline-formula><jats:alternatives><jats:tex-math>$$\\upvarepsilon$$<\/jats:tex-math><mml:math xmlns:mml=\"http:\/\/www.w3.org\/1998\/Math\/MathML\">\n                  <mml:mi>\u03b5<\/mml:mi>\n                <\/mml:math><\/jats:alternatives><\/jats:inline-formula>4 predicts increased plaque-associated inflammation.<\/jats:p>","DOI":"10.1186\/s40478-022-01375-y","type":"journal-article","created":{"date-parts":[[2022,5,7]],"date-time":"2022-05-07T13:02:37Z","timestamp":1651928557000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":18,"title":["Frontal lobe microglia, neurodegenerative protein accumulation, and cognitive function in people with HIV"],"prefix":"10.1186","volume":"10","author":[{"given":"Jacinta","family":"Murray","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gregory","family":"Meloni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Etty P.","family":"Cortes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ariadna","family":"KimSilva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michelle","family":"Jacobs","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alyssa","family":"Ramkissoon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John F.","family":"Crary","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7729-245X","authenticated-orcid":false,"given":"Susan","family":"Morgello","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,5,7]]},"reference":[{"key":"1375_CR1","doi-asserted-by":"publisher","first-page":"603","DOI":"10.1016\/j.cell.2015.12.056","volume":"164","author":"B DeStrooper","year":"2016","unstructured":"DeStrooper B, Karran E (2016) The cellular phase of Alzheimer\u2019s disease. Cell 164:603\u2013615","journal-title":"Cell"},{"key":"1375_CR2","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1016\/S0197-4580(00)00094-4","volume":"21","author":"YM Arends","year":"2000","unstructured":"Arends YM, Duyckaerts C, Rozemuller JM, Eikelenboom P, Hauw JJ (2000) Microglia, amyloid and dementia is Alzheimer disease: a correlative study. Neurobiol Aging 21:39\u201347","journal-title":"Neurobiol Aging"},{"key":"1375_CR3","doi-asserted-by":"publisher","first-page":"2924","DOI":"10.1038\/s41598-020-59869-5","volume":"10","author":"JS Friedberg","year":"2020","unstructured":"Friedberg JS, Aytan N, Cherry JD, Xia W, Standring OJ, Alvarez VE, Nicks R, Svirsky S, Meng G, Jun G, Ryu H, Au R, Stein TD (2020) Associations between brain inflammatory profiles and human neuropathology are altered base on apolipoprotein E e4 genotype. Sci Rep 10:2924. https:\/\/doi.org\/10.1038\/s41598-020-59869-5","journal-title":"Sci Rep"},{"key":"1375_CR4","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1016\/j.expneurol.2018.07.016","volume":"309","author":"DG Walker","year":"2018","unstructured":"Walker DG, Tang TM, Lue LF (2018) Increased expression of toll-like receptor 3, an antiviral signaling molecule, and related genes in Alzheimer\u2019s disease brains. Exp Neurol 309:91\u2013106","journal-title":"Exp Neurol"},{"key":"1375_CR5","doi-asserted-by":"publisher","unstructured":"Minett T, Classey J, Matthews FE, Fahrenhold M, Taga M, Brayne C, Ince PG, Nicoll JAR, Boche D, MRC CFAS (2016) Microglial immunophenotype in dementia with Alzheimer's pathology. J Neuroinflamm 13:135. https:\/\/doi.org\/10.1186\/s12974-016-0601-z","DOI":"10.1186\/s12974-016-0601-z"},{"key":"1375_CR6","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1038\/mp.2017.246","volume":"23","author":"KE Hopperton","year":"2018","unstructured":"Hopperton KE, Mohammad D, Trepanier MO, Giuliano V, Bazinet RP (2018) Markers of microglia in post-mortem brain samples from patients with Alzheimer\u2019s disease: a systematic review. Mol Psychiatry 23:177\u2013198","journal-title":"Mol Psychiatry"},{"key":"1375_CR7","doi-asserted-by":"publisher","first-page":"1276","DOI":"10.1016\/j.cell.2017.05.018","volume":"169","author":"H Keren-Shaul","year":"2017","unstructured":"Keren-Shaul H, Spinrad A, Weiner A, Matcovitch-Natan O, Dvir-Szternfeld R, Ulland TK et al (2017) A unique microglia type associated with restricting development of Alzheimer\u2019s Disease. Cell 169:1276\u20131290","journal-title":"Cell"},{"key":"1375_CR8","doi-asserted-by":"publisher","first-page":"726","DOI":"10.1111\/bpa.12717","volume":"29","author":"PJ Paasila","year":"2019","unstructured":"Paasila PJ, Davies DS, Kril JJ, Goldsbury C, Sutherland GT (2019) The relationship between the morphological subtypes of microglia and Alzheimer\u2019s disease neuropathology. Brain Pathol 29:726\u2013740","journal-title":"Brain Pathol"},{"key":"1375_CR9","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1111\/bpa.12763","volume":"30","author":"ui Y, Marks JD, Das S, Hyman BT, Se","year":"2020","unstructured":"ui Y, Marks JD, Das S, Hyman BT, Serrano-Pozo A, (2020) Characterization of the 18 kDa translocator protein (TSPO) expression in post-mortem normal and Alzheimer\u2019s disease brains. Brain Pathol 30:151\u2013164","journal-title":"Brain Pathol"},{"key":"1375_CR10","doi-asserted-by":"publisher","first-page":"19","DOI":"10.3390\/cells9091941","volume":"9","author":"BB Tournier","year":"2020","unstructured":"Tournier BB, Tsartsalis S, Ceyzeriat K, Garibotto V, Millet P (2020) In vivo TSPO signal and neuroinflammation in Alzheimer\u2019s disease. Cells 9:19. https:\/\/doi.org\/10.3390\/cells9091941","journal-title":"Cells"},{"key":"1375_CR11","doi-asserted-by":"publisher","first-page":"2550","DOI":"10.1002\/glia.23510","volume":"66","author":"WJ Streit","year":"2018","unstructured":"Streit WJ, Braak H, delTredici K, Leyh J, Lier J, Khoshbouei H et al (2018) Microglial activation occurs late during preclinical Alzheimer\u2019s disease. Glia 66:2550\u20132562","journal-title":"Glia"},{"key":"1375_CR12","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1002\/ana.25123","volume":"83","author":"PA Boyle","year":"2018","unstructured":"Boyle PA, Yu L, Wilson RS, Leurgans SE, Schneider JA, Bennett DA (2018) Person-specific contribution of neuropathologies to cognitive loss in old age. Ann Neurol 83:74\u201383","journal-title":"Ann Neurol"},{"key":"1375_CR13","doi-asserted-by":"publisher","first-page":"1182","DOI":"10.1097\/NEN.0000000000000016","volume":"72","author":"A Serrano-Pozo","year":"2013","unstructured":"Serrano-Pozo A, Qian J, Monsell SE, Frosch MP, Betensky RA, Hyman BT (2013) Examination of the clinicopathologic continuum of Alzheimer disease in the autopsy cohort of the national Alzheimer coordinating center. J Neuropathol Exp Neurol 72:1182\u20131192","journal-title":"J Neuropathol Exp Neurol"},{"key":"1375_CR14","doi-asserted-by":"publisher","first-page":"S161","DOI":"10.3233\/JAD-179939","volume":"64","author":"DA Bennett","year":"2018","unstructured":"Bennett DA, Buchman AS, Boyle PA, Barnes LL, Wilson RS, Schneider JA (2018) Religious orders study and Rush memory and aging project. J Alzheimers Dis 64:S161\u2013S189","journal-title":"J Alzheimers Dis"},{"key":"1375_CR15","doi-asserted-by":"publisher","first-page":"1221","DOI":"10.1007\/s10067-020-05372-1","volume":"40","author":"A Sood","year":"2021","unstructured":"Sood A, Raji MA (2021) Cognitive impairment in elderly patients with rheumatic disease and the effect of disease-modifying anti-rheumatic drugs. Clin Rheumatol 40:1221\u20131231","journal-title":"Clin Rheumatol"},{"key":"1375_CR16","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1186\/s40478-018-0592-3","volume":"6","author":"S Rakic","year":"2018","unstructured":"Rakic S, Hung YMA, Smith M, So D, Tayler HM, Varney W et al (2018) Systemic infection modifies the neuroinflammatory response in late stage Alzheimer\u2019s disease. Acta Neuropathol Commun 6:88. https:\/\/doi.org\/10.1186\/s40478-018-0592-3","journal-title":"Acta Neuropathol Commun"},{"key":"1375_CR17","doi-asserted-by":"publisher","first-page":"755","DOI":"10.1002\/ana.410380510","volume":"38","author":"JD Glass","year":"1995","unstructured":"Glass JD, Fedor H, Wesselingh SL, McArthur JC (1995) Immunocytochemical quantitation of human immunodeficiency virus in the brain: correlations with dementia. Ann Neurol 38:755\u2013762","journal-title":"Ann Neurol"},{"issue":"12","key":"1375_CR18","doi-asserted-by":"publisher","first-page":"1255","DOI":"10.1093\/jnen\/63.12.1255","volume":"63","author":"ES Roberts","year":"2004","unstructured":"Roberts ES, Masliah E, Fox HS (2004) CD163 identified a unique population of ramified microglia in HIV encephalitis (HIVE). J Neuropathol Exp Neurol 63(12):1255\u20131264","journal-title":"J Neuropathol Exp Neurol"},{"key":"1375_CR19","doi-asserted-by":"publisher","first-page":"431","DOI":"10.1007\/s13365-015-0410-7","volume":"22","author":"AJ Levine","year":"2016","unstructured":"Levine AJ, Soontornniyomkij V, Achim CL, Masliah E, Gelman BB, Sinsheimer JS et al (2016) Multilevel analysis of neuropathogenesis of neurocognitive impairment in HIV. J Neurovirol 22:431\u2013441","journal-title":"J Neurovirol"},{"key":"1375_CR20","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1016\/S1474-4422(12)70291-0","volume":"12","author":"CR Jack Jr","year":"2013","unstructured":"Jack CR Jr, Knopman DS, Jagust WJ, Petersen RC, Weiner MW, Aisen PS et al (2013) Tracking pathophysiological processes in Alzheimer\u2019s disease: an updated hypothetical model of dynamic biomarkers. Lancet Neurol 12:207\u2013216","journal-title":"Lancet Neurol"},{"key":"1375_CR21","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1007\/s13365-013-0162-1","volume":"19","author":"A Gongvatana","year":"2013","unstructured":"Gongvatana A, Harezlak J, Buchthal S, Daar E, Schifitto G, Campbell T et al (2013) Progressive cerebral injury in the setting of chronic HIV infection and antiretroviral therapy. J Neurovirol 19:209\u2013218","journal-title":"J Neurovirol"},{"key":"1375_CR22","doi-asserted-by":"publisher","first-page":"1403","DOI":"10.1097\/QAD.0000000000002893","volume":"35","author":"S Morgello","year":"2021","unstructured":"Morgello S, Cortes EP, Gensler G, Meloni G, Jacobs MM, Murray J et al (2021) HIV disease duration, but not active brain infection, predicts cortical amyloid beta deposition. AIDS 35:1403\u20131412","journal-title":"AIDS"},{"key":"1375_CR23","doi-asserted-by":"publisher","first-page":"759","DOI":"10.1080\/13803390490509565","volume":"26","author":"SP Woods","year":"2004","unstructured":"Woods SP, Rippeth JD, Frol AB, Levy JK, Ryan E, Soukup VM et al (2004) Interrater reliability of clinical ratings and neurocognitive diagnoses in HIV. J Clin Exp Neuropsychol 26:759\u2013778","journal-title":"J Clin Exp Neuropsychol"},{"key":"1375_CR24","doi-asserted-by":"publisher","first-page":"326","DOI":"10.1046\/j.0305-1846.2001.00334.x","volume":"27","author":"S Morgello","year":"2001","unstructured":"Morgello S, Gelman BB, Kozlowski PB, Vinters HV, Masliah E, Cornford M et al (2001) The National NeuroAIDS Tissue Consortium: a new paradigm in brain banking with an emphasis on infectious disease. Neuropathol Appl Neurobiol 27:326\u2013335","journal-title":"Neuropathol Appl Neurobiol"},{"key":"1375_CR25","doi-asserted-by":"publisher","first-page":"324","DOI":"10.1002\/(SICI)1098-1136(19990215)25:4<324::AID-GLIA2>3.0.CO;2-5","volume":"25","author":"H Akiyama","year":"1999","unstructured":"Akiyama H, Mori H, Saido T, Kondo H, Ikeda K, McGeer PL (1999) Occurrence of the diffuse amyloid b-protein (Ab) deposits with numerous Ab-containing glial cells in the cerebral cortex of patients with Alzheimer\u2019s disease. Glia 25:324\u2013331","journal-title":"Glia"},{"issue":"8","key":"1375_CR26","doi-asserted-by":"publisher","first-page":"733","DOI":"10.1093\/jnen\/59.8.733","volume":"59","author":"DR Thal","year":"2000","unstructured":"Thal DR, Rub U, Schultz C, Sassin I, Ghebremedhin E, delTredici K, Braak E, Braak H (2000) Sequence of Ab-protein deposition in the human medial temporal lobe. J Neuropathol Exp Neurol 59(8):733\u2013748","journal-title":"J Neuropathol Exp Neurol"},{"key":"1375_CR27","first-page":"16878","volume":"7","author":"P Bankhead","year":"2017","unstructured":"Bankhead P, Loughrey MB, Fernandez JA, Dombrowski Y, McArt DG, Dunne PD et al (2017) QuPath: Open source software for digital pathology image analysis. Sci Reports 7:16878","journal-title":"Sci Reports"},{"key":"1375_CR28","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1007\/s00401-009-0532-1","volume":"118","author":"C Duyckaerts","year":"2009","unstructured":"Duyckaerts C, Delatour B, Potier MC (2009) Classification and basic pathology of Alzheimer Disease. Acta Neuropathol 118:5\u201336","journal-title":"Acta Neuropathol"},{"key":"1375_CR29","doi-asserted-by":"publisher","first-page":"7","DOI":"10.3390\/ijms22010007","volume":"22","author":"N Jankovska","year":"2021","unstructured":"Jankovska N, Olejar T, Matej R (2021) Extracellular amyloid deposits in Alzheimer\u2019s and Creutzfledt-Jakob Disease: Similar behavior of different proteins? Int J Mol Sci 22:7","journal-title":"Int J Mol Sci"},{"key":"1375_CR30","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1111\/j.1365-2990.2012.01306.x","volume":"39","author":"DM Norden","year":"2013","unstructured":"Norden DM, Godbout JP (2013) Review: microglia of the aged brain: primed to be activated and resistant to regulation. Neuropathol Appl Neurobiol 39:19\u201334","journal-title":"Neuropathol Appl Neurobiol"},{"key":"1375_CR31","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1007\/s004010051002","volume":"97","author":"M Overmyer","year":"1999","unstructured":"Overmyer M, Helisalmi S, Soininen H, Laakso M, Riekkinen P, Alafuzoff I (1999) Reactive microglia in aging and dementia: an immunohistochemical study of postmortem human brain tissue. Acta Neuropathol 97:383\u2013392","journal-title":"Acta Neuropathol"},{"key":"1375_CR32","doi-asserted-by":"publisher","first-page":"439","DOI":"10.1111\/j.1750-3639.1998.tb00166.x","volume":"8","author":"R Egensperger","year":"1998","unstructured":"Egensperger R, Kosel S, vonEitzen U, Gaeber MB (1998) Microglial activation in Alzheimer disease: association with APOE genotype. Brain Pathol 8:439\u2013447","journal-title":"Brain Pathol"},{"key":"1375_CR33","doi-asserted-by":"publisher","first-page":"465","DOI":"10.1111\/jnc.13072","volume":"133","author":"LM Tai","year":"2015","unstructured":"Tai LM, Ghura S, Koster KP, Liakaite V, Maienschein-Cline M, Kanabar P, Collins N, Ben-Aissa M, Lei AZ, Bahroos N, Green SJ, Hendrickson B, vanEldik LJ, LaDu MJ (2015) APOE-modulated AB-induced neuroinflammation in Alzheimer\u2019s disease: current landscape, novel data, and future perspective. J Neurochem 133:465\u2013498","journal-title":"J Neurochem"},{"key":"1375_CR34","doi-asserted-by":"publisher","first-page":"144","DOI":"10.1097\/WNN.0000000000000071","volume":"28","author":"O Pletnikova","year":"2015","unstructured":"Pletnikova O, Rudow GL, Hyde TM, Kleinman JE, Ali SZ, Bharadwaj R, Gangadeen S, Crain BJ, Fowler DR, Rubio AI, Troncoso JC (2015) Alzheimer lesions in the autopsied brains of people 30 to 50 years of age. Cogn Behav Neurol 28:144\u2013152","journal-title":"Cogn Behav Neurol"},{"key":"1375_CR35","doi-asserted-by":"publisher","first-page":"960","DOI":"10.1097\/NEN.0b013e318232a379","volume":"70","author":"H Braak","year":"2011","unstructured":"Braak H, Thal DR, Ghebremedhin E, DelTredici K (2011) Stages of the pathologic process in Alzheimer disease: age categories from 1 to 100 years. J Neuropathol Exp Neurol 70:960\u2013969","journal-title":"J Neuropathol Exp Neurol"},{"key":"1375_CR36","doi-asserted-by":"publisher","first-page":"997","DOI":"10.1016\/S1474-4422(14)70194-2","volume":"13","author":"CR Jack Jr","year":"2014","unstructured":"Jack CR Jr, Wiste HJ, Weigand SD, Rocco WA, Knopman DS, Mielke MM et al (2014) Age-specific population frequencies of cerebral b-amyloidosis and neurodegeneration among people with normal cognitive function aged 50\u201389 years: a cross-sectional study. Lancet Neurol 13:997\u20131005","journal-title":"Lancet Neurol"},{"key":"1375_CR37","doi-asserted-by":"publisher","first-page":"782","DOI":"10.1212\/WNL.53.4.782","volume":"53","author":"L Chang","year":"1999","unstructured":"Chang L, Ernst T, Leonido-Yee M, Witt M, Speck O, Walot I, Miller EN (1999) Highly active antiretroviral therapy reverses brain metabolite abnormalities in mild HIV dementia. Neurology 53:782\u2013789","journal-title":"Neurology"},{"key":"1375_CR38","doi-asserted-by":"publisher","DOI":"10.1186\/s12981-016-0111-1","author":"SP Eholie","year":"2016","unstructured":"Eholie SP, Badje A, Kouame GM, N\u2019takpe JB, Moh R, Danel C, Anglaret X (2016) Antiretroviral treatment regardless of CD4 count: the universal answer to a contextual question. AIDS Res Ther. https:\/\/doi.org\/10.1186\/s12981-016-0111-1","journal-title":"AIDS Res Ther"},{"key":"1375_CR39","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s00401-011-0910-3","volume":"123","author":"TJ Montine","year":"2012","unstructured":"Montine TJ, Phelps CH, Beach TG, Bigio EH, Cairns NJ, Dickson DW et al (2012) National Institute on Aging-Alzheimer\u2019s Association guidelines for the neuropathologic assessment of Alzheimer\u2019s disease: a practical approach. Acta Neuropathol 123:1\u201311","journal-title":"Acta Neuropathol"},{"key":"1375_CR40","doi-asserted-by":"publisher","first-page":"8718","DOI":"10.1073\/pnas.0803526105","volume":"105","author":"TD Burt","year":"2008","unstructured":"Burt TD, Agan BK, Marconi VC, He W, Kulkarni H, Mold JE, Cavrois M, Huang Y, Mahley RW, Dolan MJ, McCune JM, Ahuja SK (2008) Apolipoprotein (apo) E4 enhances HIV-1 cell entry in vitro, and the APOE e4\/e4 genotype accelerates HIV disease progression. Proc Natl Acad Sci 105:8718\u20138723","journal-title":"Proc Natl Acad Sci"},{"key":"1375_CR41","doi-asserted-by":"publisher","first-page":"E66","DOI":"10.1073\/pnas.0806919105","volume":"105","author":"V Valcour","year":"2008","unstructured":"Valcour V, Shiramizu B, Shikuma C (2008) Frequency of apolipoprotein E4 among older compared with younger HIV patients: support for detrimental effect of E4 on survival. Proc Natl Acad Sci 105:E66","journal-title":"Proc Natl Acad Sci"},{"key":"1375_CR42","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1007\/s13365-014-0290-2","volume":"21","author":"JT Becker","year":"2015","unstructured":"Becker JT, Martinson JJ, Penugonda S, Kingsley L, Molsberry S, Reynolds S, Aronow A, Goodkin K, Levine A, Martin E, Miller EN, Munro CA, Ragin A, Sacktor N (2015) No association between Apoe4 alleles, HIV infection, age, neuropsychological outcome, or death. J Neurovirol 21:24\u201331","journal-title":"J Neurovirol"},{"key":"1375_CR43","doi-asserted-by":"publisher","first-page":"1501","DOI":"10.1097\/QAD.0000000000002932","volume":"35","author":"JC Ipser","year":"2021","unstructured":"Ipser JC, Vera JH (2021) Does duration of HIV infection substitute for age as a risk factor for amyloid deposition? AIDS 35:1501\u20131502","journal-title":"AIDS"},{"key":"1375_CR44","doi-asserted-by":"publisher","first-page":"2005","DOI":"10.1097\/QAD.0000000000001927","volume":"32","author":"V Soontornniyomkij","year":"2018","unstructured":"Soontornniyomkij V, Umlauf A, Soontornniyomkij B, Gouaux B, Ellis RJ, Levine AJ, Moore DJ, Letendre SL (2018) Association of antiretroviral therapy with brain aging changes among HIV-infected adults. AIDS 32:2005\u20132015","journal-title":"AIDS"},{"key":"1375_CR45","doi-asserted-by":"publisher","first-page":"1001","DOI":"10.1097\/QAD.0000000000002506","volume":"34","author":"JA Fields","year":"2020","unstructured":"Fields JA, Swinton MK, Soontornniyomkij B, Carson A, Achim CL (2020) Beta amyloid levels in cerebrospinal fluid of HIV-infected people vary by exposure to antiretroviral therapy. AIDS 34:1001\u20131007","journal-title":"AIDS"},{"key":"1375_CR46","doi-asserted-by":"publisher","first-page":"753","DOI":"10.3390\/v14040753","volume":"14","author":"M Trunfio","year":"2022","unstructured":"Trunfio M, Atzori C, Pasquero M, DiStefano A, Vai D, Nigra M, Imperiale D, Bonora S, DiPerri G, Calcagno A (2022) Patterns of cerebrospinal fluid Alzheimer\u2019s dementia biomarkers in people living with HIV: cross-sectional study on associated factors according to viral control, neurological confounders and neurocognition. Viruses 14:753. https:\/\/doi.org\/10.3390\/v14040753","journal-title":"Viruses"},{"key":"1375_CR47","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.639378","volume":"12","author":"JW George","year":"2021","unstructured":"George JW, Mattingly JE, Roland NJ, Small CM, Lamberty BG, Fox HS, Stauch KL (2021) Physiologically relevant concentrations of dolutegravir, emtricitabine, and efavirenz induce distinct metabolic alterations in HeLa epitherlial and BV2 microglial cells. Front Immunol 12:639378. https:\/\/doi.org\/10.3389\/fimmu.2021.639378","journal-title":"Front Immunol"},{"key":"1375_CR48","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1017\/neu.2020.19","volume":"32","author":"SS Zulu","year":"2020","unstructured":"Zulu SS, Abboussi O, Simola N, Mabandla MV, Daniels WMU (2020) Anti-HIV drugs promote b-amyloid deposition and impair learning and memory in BALB\/c mice. Acta Neuropsychiatrica 32:257\u2013264","journal-title":"Acta Neuropsychiatrica"},{"key":"1375_CR49","doi-asserted-by":"publisher","first-page":"17168","DOI":"10.1038\/s41598-019-53466-x","volume":"9","author":"JA Fields","year":"2019","unstructured":"Fields JA, Swinton MK, Carson A, Soontornniyomkij B, Lindsay C, Han MM et al (2019) Tenofovir disoproxil fumarate induces peripheral neuropathy and alters inflammation and mitochondrial biogenesis in the brains of mice. Sci Rep 9:17168. https:\/\/doi.org\/10.1038\/s41598-019-53466-x","journal-title":"Sci Rep"},{"key":"1375_CR50","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1186\/1756-6606-4-23","volume":"4","author":"B Giunta","year":"2011","unstructured":"Giunta B, Ehrhart J, Obregon DF, Lam L, Le L, Jin J et al (2011) Antiretroviral medications disrupt microglial phagocytosis of b-amyloid and increase its production by neurons: implications for HIV-associated neurocognitive disorders. Mol Brain 4:23","journal-title":"Mol Brain"},{"key":"1375_CR51","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1002\/glia.22350","volume":"61","author":"C Cunningham","year":"2013","unstructured":"Cunningham C (2013) Microglia and neurodegeneration: the role of systemic inflammation. Glia 61:71\u201390","journal-title":"Glia"},{"key":"1375_CR52","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1186\/1742-2094-11-111","volume":"11","author":"GA Rodriguez","year":"2014","unstructured":"Rodriguez GA, Tai LM, LaDu MJ, Rebeck GW (2014) Human APOE4 increases microglia reactivity at Ab plaques in a mouse model of Ab deposition. J Neuroinflamm 11:111","journal-title":"J Neuroinflamm"},{"key":"1375_CR53","doi-asserted-by":"publisher","first-page":"477","DOI":"10.1007\/s00401-020-02200-3","volume":"140","author":"AT Nguyen","year":"2020","unstructured":"Nguyen AT, Wang K, Hu G, Wang X, Miao Z, Azevedo JA et al (2020) APOE and TREM2 regulate amyloid-responsive microglia in Alzheimer\u2019s disease. Acta Neuropathol 140:477\u2013493","journal-title":"Acta Neuropathol"},{"key":"1375_CR54","doi-asserted-by":"publisher","first-page":"577185","DOI":"10.1016\/j.neuroim.2020.577185","volume":"341","author":"A Hashemiaghdam","year":"2020","unstructured":"Hashemiaghdam A, Mroczek M (2020) Microglia heterogeneity and neurodegeneration: the emerging paradigm of the role of immunity in Alzheimer\u2019s disease. J Neuroimmunol 341:577185. https:\/\/doi.org\/10.1016\/j.neuroim.2020.577185","journal-title":"J Neuroimmunol"},{"key":"1375_CR55","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1016\/j.neurobiolaging.2017.03.021","volume":"55","author":"Z Yin","year":"2017","unstructured":"Yin Z, Raj D, Saiepour N, VanDam D, Brouwer N, Holtman IR et al (2017) Immune hyperreactivity of Ab plaque-associated microglia in Alzheimer\u2019s disease. Neurobiol Aging 55:115\u2013122","journal-title":"Neurobiol Aging"},{"key":"1375_CR56","first-page":"13","volume":"7","author":"N Yanguas-Casas","year":"2020","unstructured":"Yanguas-Casas N (2020) Physiological sex differences in microglia and their relevance in neurologic disorders. Neuroimmunol Neuroinflammation 7:13\u201322","journal-title":"Neuroimmunol Neuroinflammation"},{"key":"1375_CR57","doi-asserted-by":"publisher","DOI":"10.1212\/NXI.0000000000000512","volume":"6","author":"M Gisslen","year":"2019","unstructured":"Gisslen M, Heslegrave A, Veleva E, Yilmaz A, Andersson LM, Hagberg L et al (2019) CSF concentrations of soluble TREM2 as a marker of microglial activation in HIV-1 infection. Neurol Neuroimmunol Neuroinflamm 6:e512. https:\/\/doi.org\/10.1212\/NXI.0000000000000512","journal-title":"Neurol Neuroimmunol Neuroinflamm"}],"container-title":["Acta Neuropathologica Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40478-022-01375-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s40478-022-01375-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40478-022-01375-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,5,7]],"date-time":"2022-05-07T14:04:07Z","timestamp":1651932247000},"score":1,"resource":{"primary":{"URL":"https:\/\/actaneurocomms.biomedcentral.com\/articles\/10.1186\/s40478-022-01375-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,5,7]]},"references-count":57,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2022,12]]}},"alternative-id":["1375"],"URL":"https:\/\/doi.org\/10.1186\/s40478-022-01375-y","relation":{},"ISSN":["2051-5960"],"issn-type":[{"value":"2051-5960","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,5,7]]},"assertion":[{"value":"13 March 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 April 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 May 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}],"article-number":"69"}}